Co-Diagnostics (NASDAQ:CODX) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.22 by 50 percent. This is a 23.26 percent decrease over earnings of $0.43 per share from the same period last year. The company reported quarterly sales of $27.40 million which beat the analyst consensus estimate of $20.77 million by 31.92 percent. This is a 13.98 percent increase over sales of $24.04 million the same period last year.
Co-Diagnostics Q2 EPS $0.33 Beats $0.22 Estimate, Sales $27.40M Beat $20.77M Estimate
Co-Diagnostics (NASDAQ:CODX) reported quarterly earnings of $0.33 per share which beat the analyst consensus estimate of $0.22 by 50 percent. This is a 23.26 percent decrease over earnings of $0.43 per share from the
